Table1.
Demographic and clinical characteristics of participants by the presence of CHD
| CHD + NAFLD (n = 255) | NAFLD (n = 169) | t/χ2/Z | P | |
|---|---|---|---|---|
| Gender (male) | 178 (69.8) | 88 (52.1) | 13.671 | < 0.001 |
| Age (years) | 58.5 ± 10.8 | 55.0 ± 9.9 | 3.381 | 0.001 |
| BMI (kg/m2 | 26.3 ± 3.0 | 26.2 ± 2.9 | 0.507 | 0.612 |
| Smoke [(n%)] | 135 (52.9) | 52 (30.8) | 20.268 | < 0.001 |
| HT [(n%)] | 173 (67.8) | 80 (47.3) | 17.760 | < 0.001 |
| DM [(n%)] | 100 (39.2) | 24 (14.2) | 30.735 | < 0.001 |
| SBP (mmHg) | 133.6 ± 19.4 | 131.9 ± 17.1 | 0.904 | 0.367 |
| DBP (mmHg) | 81.4 ± 13.0 | 80.4 ± 11.9 | 0.779 | 0.436 |
| ALT (U/L) | 26.3 (18.6–35.4) | 22.3 (16.2–31.9) | − 2.425 | 0.015 |
| AST (U/L) | 23.8 (19.1–29.7) | 21.7 (18.3–25.5) | − 2.585 | 0.010 |
| Scr (mmol/L) | 67.3 ± 13.7 | 64.5 ± 11.6 | 2.177 | 0.030 |
| TC (mmol/L) | 4.47 ± 1.11 | 4.37 ± 0.98 | 0.914 | 0.361 |
| TG (mmol/L) | 1.81 (1.33–2.60) | 1.62 (1.20–2.21) | − 3.040 | 0.002 |
| HDL-C (mmol/L) | 1.08 ± 0.25 | 1.18 ± 0.27 | − 3.987 | < 0.001 |
| LDL-C (mmol/L) | 2.53 ± 0.72 | 2.29 ± 0.70 | 3.521 | < 0.001 |
| FGB (mmol/L) | 5.86 (4.99–7.37) | 5.29 (4.91–5.83) | − 4.828 | < 0.001 |
| TyG | 9.10 (8.76–9.53) | 8.86 (8.53–9.17) | − 5.263 | < 0.001 |
| TyG-BMI | 239.6 (219.0–261.7) | 228.3 (215.6–246.8) | − 3.169 | 0.002 |
Data are shown as means ± SD or median (quartile). Normal values were compared using paired and unpaired Student’s t-tests, and non-normally distributed values were compared using Wilcoxon rank-sum or Mann–Whitney tests. Chi-square test was used to classification variables
BMI body mass index, HT hypertension, DM diabetes mellitus, SBP systolic blood pressure, DBP diastolic blood pressure, ALT alanine aminotransferase, AST aspartate aminotransferase, Scr serum creatinine, TC total cholesterol, TG triglycerides, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, FGB fasting plasma glucose, TyG triglyceride-glucose index, TyG-BMI TyG index with body mass index